drugset / Trial / NCT00947518

Safety of Skin Cleansing With Chlorhexidine in Preterm Low Birth Weight Infants

NCT00947518

RandomizedParallel-groupTriple-blindPrevention

Summary

The purpose of this study is to examine if single skin cleansing with 0.25% chlorhexidine affects skin condition, temperature, and bacterial colonization in stable preterm (28-36 weeks gestational age) low birth weight (1001-2000 g) infants admitted in a health facility.

Timeline

Start
2005-08
Primary completion
2006-02
Completion
2006-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Chlorhexidine Small molecule 0.25 % Topical